Print Friendly, PDF & Email


By partnering with public and private institutions HRI delivers the resources necessary to translate research findings into products for the prevention, diagnosis and treatment of disease.

HRI has a long and distinguished history of recognizing, protecting and developing novel technologies. Successful transfers include a number of major medical technologies such as the prostate specific antigen (PSA) test, photodynamic cancer therapy, pox virus vectors, a diagnostic assay for HIV tropism, and the blood thinner Angiomax.